Industries > Pharma > Automated Cannabis Testing Market Report to 2031
Automated Cannabis Testing Market Report to 2031
By Type (Terpene Profiling, Residual Solvents, Heavy Metals, Pesticide Screening, Potency Testing, Microbial Testing, Genetic Testing), By Product & Software (Analytical Instruments (Chromatography Instruments, Gas Chromatography, Liquid Chromatography, Others, Spectroscopy Instruments, Mass Spectroscopy, Atomic Spectroscopy, Other), Consumables (Chromatography Column, Supplies And Accessories, Standards And CRMS, Sample Preparation Products), Software), By End User (Testing Laboratories, Research Institute, Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)
Automated Cannabis Testing Market– our new study reveals trends, R&D progress, and predicted revenues
Where is the Automated Cannabis Test market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2031, assessing data, trends, opportunities, and business prospects there.
Discover how to stay ahead
Our Automated Cannabis Testing Market report provides tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Automated Cannabis Testing Market. See how to exploit the opportunities.
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints, and challenges), product profiles and commercial developments.
Automated Cannabis Testing Market by Type
• Terpene profiling
• Residual Solvents
• Heavy Metals
• Pesticide Screening
• Potency testing
• Microbial Testing
• Genetic Testing
Automated Cannabis Testing Market by Product & Software
• Analytical Instruments
o Chromatography Instruments
Gas Chromatography
Liquid Chromatography
Others
o Spectroscopy Instruments
o Mass Spectroscopy
o Atomic Spectroscopy
o Other
• Consumables
o Chromatography Columns
o Supplies and Accessories
o Standards and CRMS
o Sample Preparation Products
• Software
Automated Cannabis Testing Market by End Use
• Testing Laboratories
• Research Institute
• Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:
• North America
o U.S.
o Canada
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Japan
o Rest of Asia Pacific
• Latin America
o Rest of Latin America
• Middle East and Africa
o Rest of Middle East and Africa
The report also includes profiles and for some of the leading companies in the Automated Cannabis Testing Market, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
Overall world revenue for Automated Cannabis Testing Market with forecasts by type, by product & Software, and by end user each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments
Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Automated Cannabis Testing Market report helps you
In summary, our 240+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Automated Cannabis Testing Market, with forecasts for by type, by Product & Software, By End user each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 5 regional and 20 key national markets – See forecasts for the Automated Cannabis Testing Market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, Rest of Asia Pacific, Latin America and Middle East and Africa among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for Automated Cannabis Testing Market of the major companies involved in the Automated Cannabis Testing Market. Some of the company’s profiled in this report include-
• Agilent Technologies, Inc.
• Shimadzu Corporation
• MCS, Inc.,
• Restek Corporation
• A&L Canada Laboratories Inc.
• Marrone Bio Innovations
• Emerald Scientific LLC
• PerkinElmer, Inc.
• Millipore Sigma
• AB SCIEX LLC
• Vive Crop Protection
• Thermo Fisher Scientific Inc.
• LabLynx, Inc.
• While, Steep Hill Labs, Inc
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
With Information found nowhere else
Our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.
Visiongain’s study is for everybody needing commercial analyses for the global Automated Cannabis Testing Market and leading companies. You will find data, trends, and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Automated Cannabis Testing Market Report to 2031: By Type (Terpene Profiling, Residual Solvents, Heavy Metals, Pesticide Screening, Potency Testing, Microbial Testing, Genetic Testing), By Product & Software (Analytical Instruments (Chromatography Instruments, Gas Chromatography, Liquid Chromatography, Others, Spectroscopy Instruments, Mass Spectroscopy, Atomic Spectroscopy, Other), Consumables (Chromatography Column, Supplies And Accessories, Standards And CRMS, Sample Preparation Products), Software), By End User (Testing Laboratories, Research Institute, Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa). Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Automated Cannabis Testing Market
2.1. Automated Cannabis Testing Market Definition
2.2. By Type Submarkets Definitions
2.3. By Product & Software Submarkets Definitions
2.4. By End User Submarkets Definitions
3. Automated Cannabis Testing Market Overview
3.1. Global Automated Cannabis Testing Market Size and Forecast by Region
3.2. Global Automated Cannabis Testing Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Rising legalization for therapeutic & medical use.
3.3.1.2. Increasing adoption of laboratory information management system (LIMS) in Cannabis Testing Laboratories
3.3.1.3. Rising Number of Cannabis Testing Laboratories.
3.3.2. Market Restraints/Challenges
3.3.2.1. High cost associated with analytical instruments for testing.
3.3.2.2. Lack of uniform standards across the globe.
3.3.3. Opportunities
3.3.3.1. Increasing recommendation to encourage improvisation of cannabis research.
3.3.3.2. Rising awareness & increasing use of cannabis in various Product & Software.
3.3.4. Porter’s Five Forces Analysis
3.3.4.1. Competitive Rivalry
3.3.4.2. Supplier Power
3.3.4.3. Buyer Power
3.3.4.4. Threat of Substitution
3.3.4.5. Threat of New Entry
4. Global Automated Cannabis Testing Market Analysis and Forecast 2021-2031, By Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Terpene profiling
4.1.1.1. The terpenes are analysed through headspace gas chromatography (GC) with flame ionization detection (FID), mass spectrometry (MS), or both (FID/MS).
4.1.2. Residual Solvents
4.1.2.1. The solvents are volatile in nature, hence full evaporation technique (FET), headspace gas chromatography–flame ionization detection (GC-FID) is used.
4.1.3. Heavy Metals
4.1.3.1. Heavy metals are considered as one of the possible contaminants in cannabis and cannabis products.
4.1.4. Pesticide Screening
4.1.4.1. The use of gas chromatography-mass spectrometry for analysis of pesticide in cannabis samples.
4.1.5. Potency testing
4.1.5.1. Cannabis potency testing enables to measures presence of cannabinoids and detects the strength of the compounds.
4.1.6. Microbial Testing
4.1.6.1. The microbial testing is significant to ensure that cannabis users are not being exposed to harmful contaminants.
4.1.7. Genetic Testing
4.1.7.1. Use of genetic testing is beneficial for manufacturers, and consumers.
5. Global Automated Cannabis Testing Market Analysis and Forecast, 2021-2031 By Product & Software (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Analytical Instruments
5.1.1.1. Chromatography Instruments
5.1.1.1.1. Gas Chromatography
5.1.1.1.2. Liquid Chromatography
5.1.1.1.3. Others
5.1.2. Spectroscopy Instruments
5.1.2.1. Mass Spectroscopy
5.1.2.2. Atomic Spectroscopy
5.1.2.3. Other
5.1.3. Consumables
5.1.3.1. Chromatography Columns
5.1.3.2. Supplies and Accessories
5.1.3.3. Standards and CRMS
5.1.3.4. Sample Preparation Products
5.1.4. Software
6. Global Automated Cannabis Testing Market Analysis and Forecast, 2021-2031 By End User (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Testing Laboratories
6.1.2. Rising productivity & benefits of cannabis testing in laboratories procedure.
6.1.3. Research Institute
6.1.4. Research for use of cannabis in medical purpose.
6.1.5. Others
7. North America Automated Cannabis Testing Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.2. North America Automated Cannabis Testing Market Size and Forecast By Type
7.3. North America Automated Cannabis Testing Market Size and Forecast By Product & Software
7.4. North America Automated Cannabis Testing Market Size and Forecast By End User
7.5. U.S. Automated Cannabis Testing Market
7.5.1. Presence of major market players in the region.
7.6. Canada Automated Cannabis Testing Market
7.6.1. Cannabis Act reinforces to protect public health by developing strict safety and quality regulations in the region.
8. Europe Automated Cannabis Testing Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. Europe Automated Cannabis Testing Market Size and Forecast By Type
8.3. Europe Automated Cannabis Testing Market Size and Forecast By Product & Software
8.4. Europe Automated Cannabis Testing Market Size and Forecast By End User
8.5. UK Automated Cannabis Testing Market
8.5.1. Rising prevalence of inflammatory bowel disease in the region.
8.6. Germany Automated Cannabis Testing Market
8.6.1. Legalize to use cannabis for medical purposes.
8.7. France Automated Cannabis Testing Market
8.7.1. Approval of cannabis for medical purpose, the Health Ministry decree, testing will begin before March 2021 on a group of 3,000 patients in the region.
8.8. Rest of Europe Automated Cannabis Testing Market
9. Asia Pacific Automated Cannabis Testing Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Asia Pacific Automated Cannabis Testing Market Size and Forecast By Type
9.3. Asia Pacific Automated Cannabis Testing Market Size and Forecast By Product & Software
9.4. Asia Pacific Automated Cannabis Testing Market Size and Forecast By End User
9.5. China Automated Cannabis Testing Market
9.5.1. Popularity of hemp seeds to use in therapeutics.
9.6. India Automated Cannabis Testing Market
9.6.1. Investment to reinforce technological advancement, R&D and to launch advanced cannabis-based products.
9.7. Japan Automated Cannabis Testing Market
9.7.1. Approval of Epidiolex, for clinical trials to treat patients with epileptic.
9.8. Rest of Asia Pacific Automated Cannabis Testing Market
10. Latin America Automated Cannabis Testing Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Latin America Automated Cannabis Testing Market Size and Forecast By Type
10.3. Latin America Automated Cannabis Testing Market Size and Forecast By Product & Software
10.4. Latin America Automated Cannabis Testing Market Size and Forecast By End User
10.4.1. Brazil Automated Cannabis Testing Market
10.4.1.1. Approval of guidelines to use cannabis for medical purpose in the region.
10.4.2. Mexico Automated Cannabis Testing Market
10.4.2.1. Increasing use of cannabis in chronic pain management.
10.4.3. Rest of Latin America Automated Cannabis Testing Market
11. MEA Automated Cannabis Testing Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. MEA Automated Cannabis Testing Market Size and Forecast By Type
11.3. MEA Automated Cannabis Testing Market Size and Forecast By Product & Software
11.4. MEA Automated Cannabis Testing Market Size and Forecast By End User
11.5. South Africa Automated Cannabis Testing Market
11.5.1.1. Rising prevalence of IBD, emerge use of cannabis in medical purpose.
11.6. Rest of MEA Automated Cannabis Testing Market
12. Companies in the Automated Cannabis Testing Market
12.1. Agilent Technologies, Inc.
12.1.1. Company Snapshot
12.1.2. Company Overview
12.1.3. Financial Performance (2015-2020)
12.1.3.1. Net Revenue
12.1.3.2. Geographical Revenue, 2020
12.1.4. Product Offerings
12.1.5. Recent Initiatives (2017-2020)
12.2. Shimadzu Corporation
12.2.1. Company Snapshot
12.2.2. Company Overview
12.2.3. Financial Performance (2015-2020)
12.2.3.1. Net Revenue
12.2.3.2. Geographical Revenue, 2020
12.2.4. Product Offerings
12.2.5. Recent Initiatives (2017-2020)
12.3. MCS, Inc.
12.3.1. Company Snapshot
12.3.2. Company Overview
12.3.3. Financial Performance (2015-2020)
12.3.3.1. Net Revenue
12.3.3.2. Gross Profit
12.3.3.3. Geographical Revenue, 2020
12.3.4. Product Offerings
12.3.5. Recent Initiatives (2017-2020)
12.4. Restek Corporation
12.4.1. Company Snapshot
12.4.2. Company Overview
12.4.3. Financial Performance (2015-2020)
12.4.3.1. Net Revenue
12.4.3.2. Gross Profit
12.4.3.3. Geographical Revenue, 2020
12.4.4. Product Offerings
12.4.5. Recent Initiatives (2017-2020)
12.5. A&L Canada Laboratories Inc.
12.5.1. Company Snapshot
12.5.2. Company Overview
12.5.3. Financial Performance (2015-2020)
12.5.3.1. Net Revenue
12.5.3.2. Gross Profit
12.5.3.3. Geographical Revenue, 2020
12.5.4. Product Offerings
12.5.5. Recent Initiatives (2017-2020)
12.6. Marrone Bio Innovations
12.6.1. Company Snapshot
12.6.2. Company Overview
12.6.3. Financial Performance (2015-2020)
12.6.3.1. Net Revenue
12.6.3.2. Geographical Revenue, 2020
12.6.4. Product Offerings
12.6.5. Recent Initiatives (2017-2020)
12.7. Emerald Scientific LLC
12.7.1. Company Snapshot
12.7.2. Company Overview
12.7.3. Financial Performance (2015-2020)
12.7.3.1. Net Revenue
12.7.3.2. Geographical Revenue, 2020
12.7.4. Product Offerings
12.7.5. Recent Initiatives (2017-2020)
12.8. PerkinElmer, Inc.
12.8.1. Company Snapshot
12.8.2. Company Overview
12.8.3. Financial Performance (2015-2020)
12.8.3.1. Net Revenue
12.8.3.2. Geographical Revenue, 2020
12.8.4. Product Offerings
12.8.5. Recent Initiatives (2017-2020)
12.9. Millipore Sigma
12.9.1. Company Snapshot
12.9.2. Company Overview
12.9.3. Financial Performance (2015-2020)
12.9.3.1. Net Revenue
12.9.3.2. Geographical Revenue, 2020
12.9.4. Product Offerings
12.9.5. Recent Initiatives (2017-2020)
12.10. AB SCIEX LLC
12.10.1. Company Snapshot
12.10.2. Company Overview
12.10.3. Financial Performance (2015-2020)
12.10.3.1. Net Revenue
12.10.3.2. Geographical Revenue, 2020
12.10.4. Product Offerings
12.10.5. Recent Initiatives (2017-2020)
12.11. Other Notable Players
13. Conclusion
14. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1. Automated Cannabis Testing Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Automated Cannabis Testing Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Automated Cannabis Testing Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Automated Cannabis Testing Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Automated Cannabis Testing Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Automated Cannabis Testing Market Drivers & Restraints 2021
Table 7. Automated Cannabis Testing Submarket Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Automated Cannabis Testing Submarket Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Automated Cannabis Testing Submarket Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Automated Cannabis Testing Submarket Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Automated Cannabis Testing Submarket Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Terpene profiling Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13. Terpene profiling Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Terpene profiling Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Terpene profiling Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Terpene profiling Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Residual Solvents Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. Residual Solvents Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Residual Solvents Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Residual Solvents Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Residual Solvents Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Heavy Metals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23. Heavy Metals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Heavy Metals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Heavy Metals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Heavy Metals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Pesticide Screening Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28. Pesticide Screening Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Pesticide Screening Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Pesticide Screening Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Pesticide Screening Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Potency testing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 33. Potency testing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Potency testing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Potency testing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Potency testing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Potency testing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38. Microbial Testing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Microbial Testing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Microbial Testing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Microbial Testing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42. Genetic Testing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43. Genetic Testing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44. Genetic Testing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45. Genetic Testing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46. Genetic Testing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47. Automated Cannabis Testing Submarket Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 48. Automated Cannabis Testing Submarket Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 49. Automated Cannabis Testing Submarket Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 50. Automated Cannabis Testing Submarket Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 51. Automated Cannabis Testing Submarket Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 52. Analytical Instruments Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 53. Analytical Instruments Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 54. Analytical Instruments Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 55. Analytical Instruments Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 56. Analytical Instruments Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 57. Consumables Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 58. Consumables Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 59. Consumables Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 60. Consumables Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 61. Consumables Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 62. Software Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 63. Software Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 64. Software Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 65. Software Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 66. Software Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 67. Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 68. Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 69. Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 70. Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 71. Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 72. Testing Laboratories Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 73. Testing Laboratories Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 74. Testing Laboratories Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 75. Testing Laboratories Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 76. Testing Laboratories Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 77. Research Institute Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table78. Research Institute Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 79. Research Institute Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 80. Research Institute Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 81. Research Institute Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 82. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 83. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 84. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 85. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 86. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 87. Regional Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 88. Regional Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 89. Regional Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 90. Regional Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 91. Regional Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 92. North America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 93. North America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 94. North America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 95. North America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 96. North America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 97. North America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 98. North America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 99. North America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 100. North America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 101. North America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 102. North America Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 103. North America Automated Cannabis Testing Market Forecast By End User 2021-2031(US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 104. North America Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 105. North America Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 106. North America Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 107. North America Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 108. North America Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 109. North America Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 110. North America Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 111. North America Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 112. US Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 113. US Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 114. US Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 115. US Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table116. US Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 117. Canada Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 118. Canada Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 119. Canada Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 120. Canada Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %CAGR %) (COVID - Scenario W)
Table 121. Canada Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 122. Europe Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 123. Europe Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 124 Europe Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 125. Europe Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 126. Europe Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 127. Europe Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 128. Europe Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 129. Europe Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 130. Europe Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 131. Europe Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 132. Europe Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 133. Europe Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 134. Europe Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 135. Europe Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 136. Europe Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 137. Europe Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 138. Europe Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 139. Europe Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 140. Europe Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 141. Europe Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 142. UK Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 143. UK Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 144. UK Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 145. UK Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 146. UK Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 147. Germany Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 148. Germany Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 149. Germany Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 150. Germany Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 151. Germany Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 152. France Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 153. France Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 154. France Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %CAGR %) (COVID - Scenario U)
Table 155. France Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %CAGR %), (COVID - Scenario W)
Table 156. France Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 157. Rest of Europe Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 158. Rest of Europe Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 159. Rest of Europe Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 160. Rest of Europe Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR%, CAGR %) (COVID - Scenario W)
Table 161. Rest of Europe Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 162. Asia Pacific Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 163. Asia Pacific Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 164. Asia Pacific Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 165. Asia Pacific Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 166. Asia Pacific Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 167. Asia Pacific Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 168. Asia Pacific Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169. Asia Pacific Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170. Asia Pacific Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171. Asia Pacific Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172. Asia Pacific Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 173. Asia Pacific Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 174. Asia Pacific Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 175. Asia Pacific Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 176. Asia Pacific Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L
Table 177. Asia Pacific Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 178. Asia Pacific Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 179. Asia Pacific Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 180. Asia Pacific Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 181. Asia Pacific Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 182. China Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 183. China Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 184. China Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 185. China Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 186. China Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 187. India Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 188. India Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 189. India Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 190. India Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 191. India Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 192. Japan Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 193. Japan Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 194. Japan Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 195. Japan Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 196. Japan Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 197. RoAPAC Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 198. RoAPAC Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 199. RoAPAC Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 200. RoAPAC Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 201. RoAPAC Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 202. Middle East Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 203. Middle East Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 204. Middle East Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 205 Middle East Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 206. Middle East Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 207. Middle East Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 208. Middle East Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 209. Middle East Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 210. Middle East Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 211. Middle East Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 212 Middle East Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 213 Middle East Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 214. Middle East Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 215. Middle East Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 216. Middle East Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 217. Latin America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 218. Latin America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 219. Latin America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 210. Latin America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 211. Latin America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 212. Latin America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 213. Latin America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 214. Latin America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 215. Latin America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 216. Latin America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 217. Latin America Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 218. Latin America Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 219 Latin America Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 220. Latin America Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 221. Latin America Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 222 Leading 10 Automated Cannabis Testing Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 223. Agilent Technologies, Inc. Profile 2021 (CEO, HQ, Founded, Website)
Table 224. Agilent Technologies, Inc Automated Cannabis Testing Selected Recent Contracts 2021 (Date, Programme Type, Details)
Table 225. Agilent Technologies, Inc Automated Cannabis Testing Product Offering (Segment, Product Offerings)
Table 226. Shimadzu Corporation Profile 2021 (CEO, HQ, Founded, Website)
Table 227. Shimadzu Corporation Automated Cannabis Testing Product Offering (Segment, Product Offerings)
Table 228. MCS, Inc. Profile 2021 (CEO, HQ, Founded, Website)
Table 239. MCS, Inc Automated Cannabis Testing Selected Recent Contracts 2017-2020 (Date, Programme Type, Details)
Table 240. MCS, Inc Automated Cannabis Testing Product Offering (Segment, Product Offerings)
Table 241. Restek Corporation Profile 2021 (CEO, HQ, Founded, Website)
Table 242. Restek Corporation Selected Recent Contracts 2015-2021 (Date, Programme Type, Details)
Table 243. Restek Corporation Automated Cannabis Testing Product Offering (Segment, Product Offerings)
Table 244. A&L Canada Laboratories Inc. Profile 2021 (CEO, HQ, Founded, Website)
Table 245 A&L Canada Laboratories Inc Automated Cannabis Testing Product Offering (Segment, Product Offerings)
Table 246. Marrone Bio Innovations Profile 2021 (CEO, HQ, Founded, Website)
Table 247. Marrone Bio Innovations Selected Recent Contracts 2015-2021 (Date, Programme Type, Details)
Table 248 Marrone Bio Innovations Automated Cannabis Testing Product Offering (Segment, Product Offerings)
Table 249. Emerald Scientific LLC Profile 2021 (CEO, HQ, Founded, Website)
Table 250. Emerald Scientific LLC Automated Cannabis Testing Product Offering (Segment, Product Offerings)
Table 251. Perkin Elmer, Inc. Profile 2021 (CEO, HQ, Founded, Website)
Table 252. Perkin Elmer, Inc Automated Cannabis Testing Product Offering (Segment, Product Offerings)
Table 253. Millipore Sigma Profile 2021 (CEO, HQ, Founded, Website)
Table 254. Millipore Sigma Automated Cannabis Testing Product Offering (Segment, Product Offerings)
Table 255. Millipore Sigma Profile 2021 (CEO, Total Company Sales US$m, HQ, Founded, No. of Employees, Ticker, Website)
Table 256. AB SCIEX LLC Total Company Sales 2015-2021 (US$m, AGR %)
Table 257. AB SCIEX LLC Product Offering (Segment, Product Offerings)
Table 258. Other Companies Involved in the Automated Cannabis Testing Market (Company, Location)
LIST OF FIGURES
Figure 1. Automated Cannabis Testing Market Type Overview
Figure 2. Automated Cannabis Testing Market By Type Overview
Figure 3. Automated Cannabis Testing Market By Product & Software Overview
Figure 4. Automated Cannabis Testing Market By End User Overview
Figure 5 Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 6. Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 7. Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 8. Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 9. Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 10. Automated Cannabis Testing Submarket Forecast By Type 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 11. Automated Cannabis Testing Submarket Forecast By Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 12. Automated Cannabis Testing Submarket Forecast By Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 13. Automated Cannabis Testing Submarket Forecast By Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 14. Antifungal Drugs Submarket Forecast By Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 15. Antifungal Drugs Submarket Forecast By Product & Software 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 16. Antifungal Drugs Submarket Forecast By Product & Software 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 17. Antifungal Drugs Submarket Forecast By Product & Software 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 18. Antifungal Drugs Submarket Forecast By Product & Software 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 19. Antifungal Drugs Submarket Forecast By Product & Software 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 20. Antifungal Drugs Submarket Forecast By End User 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 21. Antifungal Drugs Submarket Forecast By End User 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 22. Antifungal Drugs Submarket Forecast By End User 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 23. Antifungal Drugs Submarket Forecast By End User 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 24. Antifungal Drugs Submarket Forecast By End User 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 25. Regional Automated Cannabis Testing Market Forecast 2021-2031 (Sales US$M, Global AGR %) (Before COVID)
Figure 26. Regional Automated Cannabis Testing Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario V)
Figure 27. Regional Automated Cannabis Testing Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario U)
Figure 28. Regional Automated Cannabis Testing Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario W)
Figure 29. Regional Automated Cannabis Testing Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario L)
Figure 30. North America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %) (Before COVID)
Figure 31. North America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 32. North America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 33. North America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 34. North America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 35. North America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %) (Before COVID)
Figure 36. North America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 37. North America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 38. North America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 39. North America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 40. North America Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %) (Before COVID)
Figure 41. North America Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 42. North America Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 43. North America Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 44. North America Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 45. North America Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %) (Before COVID)
Figure 46. North America Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 47. North America Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 48. North America Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 49. North America Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 50. US Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 51. US Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 52. US Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 53. US Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 54. US Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 55. Canada Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %)
Figure 56. Canada Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 57. Canada Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 58. Canada Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 59. Canada Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 60. Europe Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M)
Figure 61. Europe Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 62. Europe Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 63. Europe Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 64. Europe Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 65. Europe Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M) (Before COVID)
Figure 66. Europe Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M) (COVID - Scenario V)
Figure 67. Europe Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M) (COVID - Scenario U)
Figure 68. Europe Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M) (COVID - Scenario W)
Figure 69. Europe Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M) (COVID - Scenario L)
Figure 70. Europe Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M) (Before COVID)
Figure 71. Europe Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario V)
Figure 72. Europe Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario U)
Figure 73. Europe Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario W)
Figure 74. Europe Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario L)
Figure 75. Europe Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 76. Europe Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 77. Europe Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 78. Europe Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 79. Europe Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 80. UK Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 81. UK Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 82. UK Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID – Scenario U)
Figure 83. UK Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 84. UK Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 85. Germany Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %)
Figure 86. Germany Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 87. Germany Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 88. Germany Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 89. Germany Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 90. France Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %)
Figure 91. France Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 92. France Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 93. France Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 94. France Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 95. Rest of Europe Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 96. Rest of Europe Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 97. Rest of Europe Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 98. Rest of Europe Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 99. Rest of Europe Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 100 Asia-Pacific Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M) (Before COVID)
Figure 101. Asia-Pacific Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 102. Asia-Pacific Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 103. Asia-Pacific Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 104. Asia-Pacific Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 105. Asia-Pacific Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M)
Figure 106. Asia-Pacific Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M) (COVID - Scenario V)
Figure 107. Asia-Pacific Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M) (COVID - Scenario U)
Figure 108. Asia-Pacific Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M) (COVID - Scenario W)
Figure 109. Asia-Pacific Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M) (COVID - Scenario L)
Figure 110. Asia-Pacific Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M)
Figure 111. Asia-Pacific Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario V)
Figure 112. Asia-Pacific Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario U)
Figure 113. Asia-Pacific Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario W)
Figure 114. Asia-Pacific Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario L)
Figure 115. Asia-Pacific Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %) (Before COVID)
Figure 116. Asia-Pacific Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 117. Asia-Pacific Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 118. Asia-Pacific Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 119. Asia-Pacific Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 120. China Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %)
Figure 121. China Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 122. China Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 123 China Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 124. China Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 125. India Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %)
Figure 126. India Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 127. India Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 128. India Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 129. India Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 130. Japan Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 131. Japan Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 132. Japan Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 133. Japan Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 134. Japan Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 135. Rest of APAC Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 136. Rest of APAC Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 137 Rest of APAC Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 138. Rest of APAC Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 139. Rest of APAC Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 140. Middle East Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M)
Figure 141. Middle East Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 142. Middle East Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 143. Middle East Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 144. Middle East Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 145. Middle East Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M)
Figure 146. Middle East Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M) (COVID - Scenario V)
Figure 147 Middle East Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M) (COVID - Scenario U)
Figure 148. Middle East Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M) (COVID - Scenario W)
Figure 149. Middle East Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M) (COVID - Scenario L)
Figure 150. Middle East Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M)
Figure 151. Middle East Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario V)
Figure 152. Middle East Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario U)
Figure 153. Middle East Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario W)
Figure 154. Middle East Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario L)
Figure 155. Rest of Middle East Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %)
Figure 156. Rest of Middle East Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 157. Rest of Middle East Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 158. Rest of Middle East Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 159. Rest of Middle East Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 160. Latin America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M)
Figure 161. Latin America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 162. Latin America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 163. Latin America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 164. Latin America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 165. Latin America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M)
Figure 166. Latin America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M) (COVID - Scenario V)
Figure 167. Latin America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M) (COVID - Scenario U)
Figure 168. Latin America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M) (COVID - Scenario W)
Figure 169. Latin America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M) (COVID - Scenario L)
Figure 170. Latin America Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M)
Figure 171. Latin America Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario V)
Figure 172. Latin America Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario U)
Figure 173. Latin America Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario W)
Figure 174. Latin America Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario L)
Figure 175. Rest of Latin America Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %)
Figure 176. Rest of Latin America Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 177. Rest of Latin America Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 178. Rest of Latin America Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 179. Rest of Latin America Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 180. Porter’s Five Force Analysis
Companies Mentioned
1. Agilent Technologies, Inc.
2. Shimadzu Corporation
3. MCS, Inc.,
4. Restek Corporation
5. A&L Canada Laboratories Inc.
6. Marrone Bio Innovations
7. Emerald Scientific LLC
8. PerkinElmer, Inc.
9. Millipore Sigma
10. AB SCIEX LLC
11. Vive Crop Protection
12. Thermo Fisher Scientific Inc.
13. LabLynx, Inc.
14. While, Steep Hill Labs, Inc.
15. Astrix Technology Group
16. SC Laboratories Inc.
17. CannaSafe Analytics Pharm Labs, LLC
18. Digipath Labs, Inc
19. Bruker Corporation
20. Medicinal Genomics Corp
21. Steep Hill Halent Laboratories, Inc.
22. Hamilton Company
23. ACS Laboratories
24. SGS SA
25. Sartorius AG
26. Todaro Robotics
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Automated Cannabis Testing Market
2.1. Automated Cannabis Testing Market Definition
2.2. By Type Submarkets Definitions
2.3. By Product & Software Submarkets Definitions
2.4. By End User Submarkets Definitions
3. Automated Cannabis Testing Market Overview
3.1. Global Automated Cannabis Testing Market Size and Forecast by Region
3.2. Global Automated Cannabis Testing Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Rising legalization for therapeutic & medical use.
3.3.1.2. Increasing adoption of laboratory information management system (LIMS) in Cannabis Testing Laboratories
3.3.1.3. Rising Number of Cannabis Testing Laboratories.
3.3.2. Market Restraints/Challenges
3.3.2.1. High cost associated with analytical instruments for testing.
3.3.2.2. Lack of uniform standards across the globe.
3.3.3. Opportunities
3.3.3.1. Increasing recommendation to encourage improvisation of cannabis research.
3.3.3.2. Rising awareness & increasing use of cannabis in various Product & Software.
3.3.4. Porter’s Five Forces Analysis
3.3.4.1. Competitive Rivalry
3.3.4.2. Supplier Power
3.3.4.3. Buyer Power
3.3.4.4. Threat of Substitution
3.3.4.5. Threat of New Entry
4. Global Automated Cannabis Testing Market Analysis and Forecast 2021-2031, By Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Terpene profiling
4.1.1.1. The terpenes are analysed through headspace gas chromatography (GC) with flame ionization detection (FID), mass spectrometry (MS), or both (FID/MS).
4.1.2. Residual Solvents
4.1.2.1. The solvents are volatile in nature, hence full evaporation technique (FET), headspace gas chromatography–flame ionization detection (GC-FID) is used.
4.1.3. Heavy Metals
4.1.3.1. Heavy metals are considered as one of the possible contaminants in cannabis and cannabis products.
4.1.4. Pesticide Screening
4.1.4.1. The use of gas chromatography-mass spectrometry for analysis of pesticide in cannabis samples.
4.1.5. Potency testing
4.1.5.1. Cannabis potency testing enables to measures presence of cannabinoids and detects the strength of the compounds.
4.1.6. Microbial Testing
4.1.6.1. The microbial testing is significant to ensure that cannabis users are not being exposed to harmful contaminants.
4.1.7. Genetic Testing
4.1.7.1. Use of genetic testing is beneficial for manufacturers, and consumers.
5. Global Automated Cannabis Testing Market Analysis and Forecast, 2021-2031 By Product & Software (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Analytical Instruments
5.1.1.1. Chromatography Instruments
5.1.1.1.1. Gas Chromatography
5.1.1.1.2. Liquid Chromatography
5.1.1.1.3. Others
5.1.2. Spectroscopy Instruments
5.1.2.1. Mass Spectroscopy
5.1.2.2. Atomic Spectroscopy
5.1.2.3. Other
5.1.3. Consumables
5.1.3.1. Chromatography Columns
5.1.3.2. Supplies and Accessories
5.1.3.3. Standards and CRMS
5.1.3.4. Sample Preparation Products
5.1.4. Software
6. Global Automated Cannabis Testing Market Analysis and Forecast, 2021-2031 By End User (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Testing Laboratories
6.1.2. Rising productivity & benefits of cannabis testing in laboratories procedure.
6.1.3. Research Institute
6.1.4. Research for use of cannabis in medical purpose.
6.1.5. Others
7. North America Automated Cannabis Testing Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.2. North America Automated Cannabis Testing Market Size and Forecast By Type
7.3. North America Automated Cannabis Testing Market Size and Forecast By Product & Software
7.4. North America Automated Cannabis Testing Market Size and Forecast By End User
7.5. U.S. Automated Cannabis Testing Market
7.5.1. Presence of major market players in the region.
7.6. Canada Automated Cannabis Testing Market
7.6.1. Cannabis Act reinforces to protect public health by developing strict safety and quality regulations in the region.
8. Europe Automated Cannabis Testing Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. Europe Automated Cannabis Testing Market Size and Forecast By Type
8.3. Europe Automated Cannabis Testing Market Size and Forecast By Product & Software
8.4. Europe Automated Cannabis Testing Market Size and Forecast By End User
8.5. UK Automated Cannabis Testing Market
8.5.1. Rising prevalence of inflammatory bowel disease in the region.
8.6. Germany Automated Cannabis Testing Market
8.6.1. Legalize to use cannabis for medical purposes.
8.7. France Automated Cannabis Testing Market
8.7.1. Approval of cannabis for medical purpose, the Health Ministry decree, testing will begin before March 2021 on a group of 3,000 patients in the region.
8.8. Rest of Europe Automated Cannabis Testing Market
9. Asia Pacific Automated Cannabis Testing Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Asia Pacific Automated Cannabis Testing Market Size and Forecast By Type
9.3. Asia Pacific Automated Cannabis Testing Market Size and Forecast By Product & Software
9.4. Asia Pacific Automated Cannabis Testing Market Size and Forecast By End User
9.5. China Automated Cannabis Testing Market
9.5.1. Popularity of hemp seeds to use in therapeutics.
9.6. India Automated Cannabis Testing Market
9.6.1. Investment to reinforce technological advancement, R&D and to launch advanced cannabis-based products.
9.7. Japan Automated Cannabis Testing Market
9.7.1. Approval of Epidiolex, for clinical trials to treat patients with epileptic.
9.8. Rest of Asia Pacific Automated Cannabis Testing Market
10. Latin America Automated Cannabis Testing Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Latin America Automated Cannabis Testing Market Size and Forecast By Type
10.3. Latin America Automated Cannabis Testing Market Size and Forecast By Product & Software
10.4. Latin America Automated Cannabis Testing Market Size and Forecast By End User
10.4.1. Brazil Automated Cannabis Testing Market
10.4.1.1. Approval of guidelines to use cannabis for medical purpose in the region.
10.4.2. Mexico Automated Cannabis Testing Market
10.4.2.1. Increasing use of cannabis in chronic pain management.
10.4.3. Rest of Latin America Automated Cannabis Testing Market
11. MEA Automated Cannabis Testing Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. MEA Automated Cannabis Testing Market Size and Forecast By Type
11.3. MEA Automated Cannabis Testing Market Size and Forecast By Product & Software
11.4. MEA Automated Cannabis Testing Market Size and Forecast By End User
11.5. South Africa Automated Cannabis Testing Market
11.5.1.1. Rising prevalence of IBD, emerge use of cannabis in medical purpose.
11.6. Rest of MEA Automated Cannabis Testing Market
12. Companies in the Automated Cannabis Testing Market
12.1. Agilent Technologies, Inc.
12.1.1. Company Snapshot
12.1.2. Company Overview
12.1.3. Financial Performance (2015-2020)
12.1.3.1. Net Revenue
12.1.3.2. Geographical Revenue, 2020
12.1.4. Product Offerings
12.1.5. Recent Initiatives (2017-2020)
12.2. Shimadzu Corporation
12.2.1. Company Snapshot
12.2.2. Company Overview
12.2.3. Financial Performance (2015-2020)
12.2.3.1. Net Revenue
12.2.3.2. Geographical Revenue, 2020
12.2.4. Product Offerings
12.2.5. Recent Initiatives (2017-2020)
12.3. MCS, Inc.
12.3.1. Company Snapshot
12.3.2. Company Overview
12.3.3. Financial Performance (2015-2020)
12.3.3.1. Net Revenue
12.3.3.2. Gross Profit
12.3.3.3. Geographical Revenue, 2020
12.3.4. Product Offerings
12.3.5. Recent Initiatives (2017-2020)
12.4. Restek Corporation
12.4.1. Company Snapshot
12.4.2. Company Overview
12.4.3. Financial Performance (2015-2020)
12.4.3.1. Net Revenue
12.4.3.2. Gross Profit
12.4.3.3. Geographical Revenue, 2020
12.4.4. Product Offerings
12.4.5. Recent Initiatives (2017-2020)
12.5. A&L Canada Laboratories Inc.
12.5.1. Company Snapshot
12.5.2. Company Overview
12.5.3. Financial Performance (2015-2020)
12.5.3.1. Net Revenue
12.5.3.2. Gross Profit
12.5.3.3. Geographical Revenue, 2020
12.5.4. Product Offerings
12.5.5. Recent Initiatives (2017-2020)
12.6. Marrone Bio Innovations
12.6.1. Company Snapshot
12.6.2. Company Overview
12.6.3. Financial Performance (2015-2020)
12.6.3.1. Net Revenue
12.6.3.2. Geographical Revenue, 2020
12.6.4. Product Offerings
12.6.5. Recent Initiatives (2017-2020)
12.7. Emerald Scientific LLC
12.7.1. Company Snapshot
12.7.2. Company Overview
12.7.3. Financial Performance (2015-2020)
12.7.3.1. Net Revenue
12.7.3.2. Geographical Revenue, 2020
12.7.4. Product Offerings
12.7.5. Recent Initiatives (2017-2020)
12.8. PerkinElmer, Inc.
12.8.1. Company Snapshot
12.8.2. Company Overview
12.8.3. Financial Performance (2015-2020)
12.8.3.1. Net Revenue
12.8.3.2. Geographical Revenue, 2020
12.8.4. Product Offerings
12.8.5. Recent Initiatives (2017-2020)
12.9. Millipore Sigma
12.9.1. Company Snapshot
12.9.2. Company Overview
12.9.3. Financial Performance (2015-2020)
12.9.3.1. Net Revenue
12.9.3.2. Geographical Revenue, 2020
12.9.4. Product Offerings
12.9.5. Recent Initiatives (2017-2020)
12.10. AB SCIEX LLC
12.10.1. Company Snapshot
12.10.2. Company Overview
12.10.3. Financial Performance (2015-2020)
12.10.3.1. Net Revenue
12.10.3.2. Geographical Revenue, 2020
12.10.4. Product Offerings
12.10.5. Recent Initiatives (2017-2020)
12.11. Other Notable Players
13. Conclusion
14. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1. Automated Cannabis Testing Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Automated Cannabis Testing Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Automated Cannabis Testing Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Automated Cannabis Testing Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Automated Cannabis Testing Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Automated Cannabis Testing Market Drivers & Restraints 2021
Table 7. Automated Cannabis Testing Submarket Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Automated Cannabis Testing Submarket Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Automated Cannabis Testing Submarket Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Automated Cannabis Testing Submarket Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Automated Cannabis Testing Submarket Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Terpene profiling Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13. Terpene profiling Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Terpene profiling Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Terpene profiling Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Terpene profiling Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Residual Solvents Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. Residual Solvents Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Residual Solvents Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Residual Solvents Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Residual Solvents Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Heavy Metals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23. Heavy Metals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Heavy Metals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Heavy Metals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Heavy Metals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Pesticide Screening Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28. Pesticide Screening Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Pesticide Screening Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Pesticide Screening Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Pesticide Screening Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Potency testing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 33. Potency testing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Potency testing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Potency testing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Potency testing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Potency testing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38. Microbial Testing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Microbial Testing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Microbial Testing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Microbial Testing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42. Genetic Testing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43. Genetic Testing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44. Genetic Testing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45. Genetic Testing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46. Genetic Testing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47. Automated Cannabis Testing Submarket Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 48. Automated Cannabis Testing Submarket Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 49. Automated Cannabis Testing Submarket Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 50. Automated Cannabis Testing Submarket Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 51. Automated Cannabis Testing Submarket Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 52. Analytical Instruments Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 53. Analytical Instruments Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 54. Analytical Instruments Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 55. Analytical Instruments Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 56. Analytical Instruments Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 57. Consumables Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 58. Consumables Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 59. Consumables Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 60. Consumables Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 61. Consumables Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 62. Software Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 63. Software Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 64. Software Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 65. Software Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 66. Software Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 67. Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 68. Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 69. Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 70. Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 71. Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 72. Testing Laboratories Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 73. Testing Laboratories Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 74. Testing Laboratories Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 75. Testing Laboratories Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 76. Testing Laboratories Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 77. Research Institute Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table78. Research Institute Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 79. Research Institute Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 80. Research Institute Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 81. Research Institute Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 82. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 83. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 84. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 85. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 86. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 87. Regional Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 88. Regional Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 89. Regional Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 90. Regional Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 91. Regional Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 92. North America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 93. North America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 94. North America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 95. North America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 96. North America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 97. North America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 98. North America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 99. North America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 100. North America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 101. North America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 102. North America Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 103. North America Automated Cannabis Testing Market Forecast By End User 2021-2031(US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 104. North America Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 105. North America Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 106. North America Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 107. North America Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 108. North America Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 109. North America Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 110. North America Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 111. North America Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 112. US Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 113. US Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 114. US Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 115. US Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table116. US Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 117. Canada Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 118. Canada Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 119. Canada Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 120. Canada Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %CAGR %) (COVID - Scenario W)
Table 121. Canada Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 122. Europe Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 123. Europe Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 124 Europe Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 125. Europe Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 126. Europe Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 127. Europe Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 128. Europe Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 129. Europe Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 130. Europe Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 131. Europe Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 132. Europe Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 133. Europe Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 134. Europe Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 135. Europe Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 136. Europe Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 137. Europe Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 138. Europe Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 139. Europe Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 140. Europe Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 141. Europe Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 142. UK Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 143. UK Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 144. UK Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 145. UK Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 146. UK Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 147. Germany Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 148. Germany Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 149. Germany Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 150. Germany Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 151. Germany Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 152. France Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 153. France Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 154. France Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %CAGR %) (COVID - Scenario U)
Table 155. France Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %CAGR %), (COVID - Scenario W)
Table 156. France Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 157. Rest of Europe Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 158. Rest of Europe Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 159. Rest of Europe Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 160. Rest of Europe Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR%, CAGR %) (COVID - Scenario W)
Table 161. Rest of Europe Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 162. Asia Pacific Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 163. Asia Pacific Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 164. Asia Pacific Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 165. Asia Pacific Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 166. Asia Pacific Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 167. Asia Pacific Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 168. Asia Pacific Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169. Asia Pacific Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170. Asia Pacific Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171. Asia Pacific Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172. Asia Pacific Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 173. Asia Pacific Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 174. Asia Pacific Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 175. Asia Pacific Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 176. Asia Pacific Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L
Table 177. Asia Pacific Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 178. Asia Pacific Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 179. Asia Pacific Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 180. Asia Pacific Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 181. Asia Pacific Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 182. China Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 183. China Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 184. China Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 185. China Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 186. China Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 187. India Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 188. India Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 189. India Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 190. India Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 191. India Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 192. Japan Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 193. Japan Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 194. Japan Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 195. Japan Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 196. Japan Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 197. RoAPAC Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 198. RoAPAC Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 199. RoAPAC Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 200. RoAPAC Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 201. RoAPAC Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 202. Middle East Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 203. Middle East Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 204. Middle East Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 205 Middle East Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 206. Middle East Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 207. Middle East Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 208. Middle East Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 209. Middle East Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 210. Middle East Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 211. Middle East Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 212 Middle East Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 213 Middle East Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 214. Middle East Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 215. Middle East Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 216. Middle East Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 217. Latin America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 218. Latin America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 219. Latin America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 210. Latin America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 211. Latin America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 212. Latin America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 213. Latin America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 214. Latin America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 215. Latin America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 216. Latin America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 217. Latin America Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 218. Latin America Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 219 Latin America Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 220. Latin America Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 221. Latin America Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 222 Leading 10 Automated Cannabis Testing Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 223. Agilent Technologies, Inc. Profile 2021 (CEO, HQ, Founded, Website)
Table 224. Agilent Technologies, Inc Automated Cannabis Testing Selected Recent Contracts 2021 (Date, Programme Type, Details)
Table 225. Agilent Technologies, Inc Automated Cannabis Testing Product Offering (Segment, Product Offerings)
Table 226. Shimadzu Corporation Profile 2021 (CEO, HQ, Founded, Website)
Table 227. Shimadzu Corporation Automated Cannabis Testing Product Offering (Segment, Product Offerings)
Table 228. MCS, Inc. Profile 2021 (CEO, HQ, Founded, Website)
Table 239. MCS, Inc Automated Cannabis Testing Selected Recent Contracts 2017-2020 (Date, Programme Type, Details)
Table 240. MCS, Inc Automated Cannabis Testing Product Offering (Segment, Product Offerings)
Table 241. Restek Corporation Profile 2021 (CEO, HQ, Founded, Website)
Table 242. Restek Corporation Selected Recent Contracts 2015-2021 (Date, Programme Type, Details)
Table 243. Restek Corporation Automated Cannabis Testing Product Offering (Segment, Product Offerings)
Table 244. A&L Canada Laboratories Inc. Profile 2021 (CEO, HQ, Founded, Website)
Table 245 A&L Canada Laboratories Inc Automated Cannabis Testing Product Offering (Segment, Product Offerings)
Table 246. Marrone Bio Innovations Profile 2021 (CEO, HQ, Founded, Website)
Table 247. Marrone Bio Innovations Selected Recent Contracts 2015-2021 (Date, Programme Type, Details)
Table 248 Marrone Bio Innovations Automated Cannabis Testing Product Offering (Segment, Product Offerings)
Table 249. Emerald Scientific LLC Profile 2021 (CEO, HQ, Founded, Website)
Table 250. Emerald Scientific LLC Automated Cannabis Testing Product Offering (Segment, Product Offerings)
Table 251. Perkin Elmer, Inc. Profile 2021 (CEO, HQ, Founded, Website)
Table 252. Perkin Elmer, Inc Automated Cannabis Testing Product Offering (Segment, Product Offerings)
Table 253. Millipore Sigma Profile 2021 (CEO, HQ, Founded, Website)
Table 254. Millipore Sigma Automated Cannabis Testing Product Offering (Segment, Product Offerings)
Table 255. Millipore Sigma Profile 2021 (CEO, Total Company Sales US$m, HQ, Founded, No. of Employees, Ticker, Website)
Table 256. AB SCIEX LLC Total Company Sales 2015-2021 (US$m, AGR %)
Table 257. AB SCIEX LLC Product Offering (Segment, Product Offerings)
Table 258. Other Companies Involved in the Automated Cannabis Testing Market (Company, Location)
LIST OF FIGURES
Figure 1. Automated Cannabis Testing Market Type Overview
Figure 2. Automated Cannabis Testing Market By Type Overview
Figure 3. Automated Cannabis Testing Market By Product & Software Overview
Figure 4. Automated Cannabis Testing Market By End User Overview
Figure 5 Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 6. Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 7. Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 8. Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 9. Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 10. Automated Cannabis Testing Submarket Forecast By Type 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 11. Automated Cannabis Testing Submarket Forecast By Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 12. Automated Cannabis Testing Submarket Forecast By Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 13. Automated Cannabis Testing Submarket Forecast By Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 14. Antifungal Drugs Submarket Forecast By Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 15. Antifungal Drugs Submarket Forecast By Product & Software 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 16. Antifungal Drugs Submarket Forecast By Product & Software 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 17. Antifungal Drugs Submarket Forecast By Product & Software 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 18. Antifungal Drugs Submarket Forecast By Product & Software 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 19. Antifungal Drugs Submarket Forecast By Product & Software 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 20. Antifungal Drugs Submarket Forecast By End User 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 21. Antifungal Drugs Submarket Forecast By End User 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 22. Antifungal Drugs Submarket Forecast By End User 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 23. Antifungal Drugs Submarket Forecast By End User 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 24. Antifungal Drugs Submarket Forecast By End User 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 25. Regional Automated Cannabis Testing Market Forecast 2021-2031 (Sales US$M, Global AGR %) (Before COVID)
Figure 26. Regional Automated Cannabis Testing Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario V)
Figure 27. Regional Automated Cannabis Testing Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario U)
Figure 28. Regional Automated Cannabis Testing Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario W)
Figure 29. Regional Automated Cannabis Testing Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario L)
Figure 30. North America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %) (Before COVID)
Figure 31. North America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 32. North America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 33. North America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 34. North America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 35. North America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %) (Before COVID)
Figure 36. North America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 37. North America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 38. North America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 39. North America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 40. North America Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %) (Before COVID)
Figure 41. North America Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 42. North America Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 43. North America Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 44. North America Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 45. North America Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %) (Before COVID)
Figure 46. North America Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 47. North America Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 48. North America Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 49. North America Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 50. US Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 51. US Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 52. US Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 53. US Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 54. US Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 55. Canada Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %)
Figure 56. Canada Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 57. Canada Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 58. Canada Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 59. Canada Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 60. Europe Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M)
Figure 61. Europe Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 62. Europe Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 63. Europe Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 64. Europe Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 65. Europe Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M) (Before COVID)
Figure 66. Europe Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M) (COVID - Scenario V)
Figure 67. Europe Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M) (COVID - Scenario U)
Figure 68. Europe Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M) (COVID - Scenario W)
Figure 69. Europe Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M) (COVID - Scenario L)
Figure 70. Europe Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M) (Before COVID)
Figure 71. Europe Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario V)
Figure 72. Europe Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario U)
Figure 73. Europe Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario W)
Figure 74. Europe Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario L)
Figure 75. Europe Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 76. Europe Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 77. Europe Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 78. Europe Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 79. Europe Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 80. UK Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 81. UK Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 82. UK Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID – Scenario U)
Figure 83. UK Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 84. UK Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 85. Germany Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %)
Figure 86. Germany Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 87. Germany Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 88. Germany Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 89. Germany Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 90. France Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %)
Figure 91. France Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 92. France Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 93. France Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 94. France Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 95. Rest of Europe Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 96. Rest of Europe Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 97. Rest of Europe Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 98. Rest of Europe Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 99. Rest of Europe Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 100 Asia-Pacific Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M) (Before COVID)
Figure 101. Asia-Pacific Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 102. Asia-Pacific Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 103. Asia-Pacific Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 104. Asia-Pacific Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 105. Asia-Pacific Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M)
Figure 106. Asia-Pacific Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M) (COVID - Scenario V)
Figure 107. Asia-Pacific Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M) (COVID - Scenario U)
Figure 108. Asia-Pacific Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M) (COVID - Scenario W)
Figure 109. Asia-Pacific Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M) (COVID - Scenario L)
Figure 110. Asia-Pacific Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M)
Figure 111. Asia-Pacific Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario V)
Figure 112. Asia-Pacific Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario U)
Figure 113. Asia-Pacific Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario W)
Figure 114. Asia-Pacific Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario L)
Figure 115. Asia-Pacific Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, AGR %) (Before COVID)
Figure 116. Asia-Pacific Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 117. Asia-Pacific Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 118. Asia-Pacific Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 119. Asia-Pacific Automated Cannabis Testing Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 120. China Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %)
Figure 121. China Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 122. China Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 123 China Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 124. China Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 125. India Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %)
Figure 126. India Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 127. India Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 128. India Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 129. India Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 130. Japan Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 131. Japan Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 132. Japan Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 133. Japan Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 134. Japan Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 135. Rest of APAC Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 136. Rest of APAC Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 137 Rest of APAC Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 138. Rest of APAC Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 139. Rest of APAC Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 140. Middle East Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M)
Figure 141. Middle East Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 142. Middle East Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 143. Middle East Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 144. Middle East Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 145. Middle East Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M)
Figure 146. Middle East Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M) (COVID - Scenario V)
Figure 147 Middle East Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M) (COVID - Scenario U)
Figure 148. Middle East Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M) (COVID - Scenario W)
Figure 149. Middle East Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M) (COVID - Scenario L)
Figure 150. Middle East Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M)
Figure 151. Middle East Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario V)
Figure 152. Middle East Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario U)
Figure 153. Middle East Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario W)
Figure 154. Middle East Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario L)
Figure 155. Rest of Middle East Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %)
Figure 156. Rest of Middle East Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 157. Rest of Middle East Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 158. Rest of Middle East Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 159. Rest of Middle East Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 160. Latin America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M)
Figure 161. Latin America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 162. Latin America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 163. Latin America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 164. Latin America Automated Cannabis Testing Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 165. Latin America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M)
Figure 166. Latin America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M) (COVID - Scenario V)
Figure 167. Latin America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M) (COVID - Scenario U)
Figure 168. Latin America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M) (COVID - Scenario W)
Figure 169. Latin America Automated Cannabis Testing Market Forecast By Product & Software 2021-2031 (US$M) (COVID - Scenario L)
Figure 170. Latin America Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M)
Figure 171. Latin America Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario V)
Figure 172. Latin America Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario U)
Figure 173. Latin America Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario W)
Figure 174. Latin America Automated Cannabis Testing Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario L)
Figure 175. Rest of Latin America Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %)
Figure 176. Rest of Latin America Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 177. Rest of Latin America Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 178. Rest of Latin America Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 179. Rest of Latin America Automated Cannabis Testing Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 180. Porter’s Five Force Analysis
Companies Mentioned
1. Agilent Technologies, Inc.
2. Shimadzu Corporation
3. MCS, Inc.,
4. Restek Corporation
5. A&L Canada Laboratories Inc.
6. Marrone Bio Innovations
7. Emerald Scientific LLC
8. PerkinElmer, Inc.
9. Millipore Sigma
10. AB SCIEX LLC
11. Vive Crop Protection
12. Thermo Fisher Scientific Inc.
13. LabLynx, Inc.
14. While, Steep Hill Labs, Inc.
15. Astrix Technology Group
16. SC Laboratories Inc.
17. CannaSafe Analytics Pharm Labs, LLC
18. Digipath Labs, Inc
19. Bruker Corporation
20. Medicinal Genomics Corp
21. Steep Hill Halent Laboratories, Inc.
22. Hamilton Company
23. ACS Laboratories
24. SGS SA
25. Sartorius AG
26. Todaro Robotics
Companies Profiled in the Report
1. Agilent Technologies, Inc.
2. Shimadzu Corporation
3. MCS, Inc.,
4. Restek Corporation
5. A&L Canada Laboratories Inc.
6. Marrone Bio Innovations
7. Emerald Scientific LLC
8. PerkinElmer, Inc.
9. Millipore Sigma
10. AB SCIEX LLC
11. Vive Crop Protection
12. Thermo Fisher Scientific Inc.
13. LabLynx, Inc.
14. While, Steep Hill Labs, Inc.
List of Companies Mentioned in the Report:
1. Agilent Technologies, Inc.
2. Shimadzu Corporation
3. MCS, Inc.,
4. Restek Corporation
5. A&L Canada Laboratories Inc.
6. Marrone Bio Innovations
7. Emerald Scientific LLC
8. PerkinElmer, Inc.
9. Millipore Sigma
10. AB SCIEX LLC
11. Vive Crop Protection
12. Thermo Fisher Scientific Inc.
13. LabLynx, Inc.
14. While, Steep Hill Labs, Inc.
15. Astrix Technology Group
16. SC Laboratories Inc.
17. CannaSafe Analytics Pharm Labs, LLC
18. Digipath Labs, Inc
19. Bruker Corporation
20. Medicinal Genomics Corp
21. Steep Hill Halent Laboratories, Inc.
22. Hamilton Company
23. ACS Laboratories
24. SGS SA
25. Sartorius AG
26. Todaro Robotics
List of Organizations Mentioned in the Report
1. World Health Organization
2. National Center for Biotechnology Information
3. U.S. National Library of Medicine
4. Centers for Disease Control and Prevention (CDC),
5. The American Society for Testing and Materials
6. The ANSI National Accreditation Board (ANAB)
7. The National Agency for Health Surveillance of Brazil,
8. The American Oil Chemists Society
9. Hellenic Society of Gastroenterology
10. American Academy of Dermatology Association.
11. Bingham Memorial Hospital.
12. American College of Cardiology
13. National Center for Biotechnology Information
14. National Institute for Health and Care Excellence
15. European Association of Hospital Pharmacy
16. American Heart Association
17. Stanford Healthcare
18. Epidemic Analysis Dashboard
19. American University Radio
20. Massachusetts Medical Society.
21. The European Medicines Agency (EMA)
22. US Food & Drug Administration
23. US National Library of Medicine
24. National Institutes of Health
25. The Biomedical Advanced Research and Development Authority (BARDA)
26. National Organisation for Rare Diseases
27. National Association for Biomedical Research
28. Center for Disease Control and Prevention CDC
29. Center for Diseases Dynamics, Economics & Policy (CDDEP)
30. The Global Health Security Agenda (GHSA)
31. American Society of Microbiology
32. National Institute on Drug Abuse
33. The United Nations Office on Drugs and Crime (UNODC)
1. Agilent Technologies, Inc.
2. Shimadzu Corporation
3. MCS, Inc.,
4. Restek Corporation
5. A&L Canada Laboratories Inc.
6. Marrone Bio Innovations
7. Emerald Scientific LLC
8. PerkinElmer, Inc.
9. Millipore Sigma
10. AB SCIEX LLC
11. Vive Crop Protection
12. Thermo Fisher Scientific Inc.
13. LabLynx, Inc.
14. While, Steep Hill Labs, Inc.
List of Companies Mentioned in the Report:
1. Agilent Technologies, Inc.
2. Shimadzu Corporation
3. MCS, Inc.,
4. Restek Corporation
5. A&L Canada Laboratories Inc.
6. Marrone Bio Innovations
7. Emerald Scientific LLC
8. PerkinElmer, Inc.
9. Millipore Sigma
10. AB SCIEX LLC
11. Vive Crop Protection
12. Thermo Fisher Scientific Inc.
13. LabLynx, Inc.
14. While, Steep Hill Labs, Inc.
15. Astrix Technology Group
16. SC Laboratories Inc.
17. CannaSafe Analytics Pharm Labs, LLC
18. Digipath Labs, Inc
19. Bruker Corporation
20. Medicinal Genomics Corp
21. Steep Hill Halent Laboratories, Inc.
22. Hamilton Company
23. ACS Laboratories
24. SGS SA
25. Sartorius AG
26. Todaro Robotics
List of Organizations Mentioned in the Report
1. World Health Organization
2. National Center for Biotechnology Information
3. U.S. National Library of Medicine
4. Centers for Disease Control and Prevention (CDC),
5. The American Society for Testing and Materials
6. The ANSI National Accreditation Board (ANAB)
7. The National Agency for Health Surveillance of Brazil,
8. The American Oil Chemists Society
9. Hellenic Society of Gastroenterology
10. American Academy of Dermatology Association.
11. Bingham Memorial Hospital.
12. American College of Cardiology
13. National Center for Biotechnology Information
14. National Institute for Health and Care Excellence
15. European Association of Hospital Pharmacy
16. American Heart Association
17. Stanford Healthcare
18. Epidemic Analysis Dashboard
19. American University Radio
20. Massachusetts Medical Society.
21. The European Medicines Agency (EMA)
22. US Food & Drug Administration
23. US National Library of Medicine
24. National Institutes of Health
25. The Biomedical Advanced Research and Development Authority (BARDA)
26. National Organisation for Rare Diseases
27. National Association for Biomedical Research
28. Center for Disease Control and Prevention CDC
29. Center for Diseases Dynamics, Economics & Policy (CDDEP)
30. The Global Health Security Agenda (GHSA)
31. American Society of Microbiology
32. National Institute on Drug Abuse
33. The United Nations Office on Drugs and Crime (UNODC)
Download sample pages
Complete the form below to download your free sample pages for Automated Cannabis Testing Market Report to 2031Related reports
Antibiotic Residue Test Kits Market Report to 2031
Where is the Antibiotic Residue Test Kit market heading? If you are involved in this sector you must read this...Full DetailsPublished: 01 January 1970Tissue Diagnostics Market Report 2021-2031
Where the Tissue Diagnostics market is heading? If you are involved in this industry you must read this newly updated...
Full DetailsPublished: 01 January 1970Drugs of Abuse Testing Market Report 2021-2031
Drugs Abuse has risen very significantly in few last year as compared to previous once and expected to continuously rise...Full DetailsPublished: 01 January 1970Companion Diagnostics (CDx) Market Report 2021-2031
Over the last few years, companion diagnostics has gained widespread attention due to the technological advancements, growing demand for precision...Full DetailsPublished: 07 June 2021Antigen Skin Test Market Report to 2031
Where is the Global Antigen Skin Test market heading? If you are involved in this sector you must read this...Full DetailsPublished: 01 January 1970Point of Care Diagnostics Market Report 2021-2031
Rise in prevalence of target condition has led to increase in adoption of PoC diagnostic in clinics, hospitals and even...Full DetailsPublished: 02 March 2021Antinuclear Antibody Test Market Report to 2031
Where is the Global Antinuclear Antibody Test market heading? If you are involved in this sector you must read this...Full DetailsPublished: 01 January 1970Automated Immunoassay Analysers Market Report to 2031
Where is the Automated Immunoassay Analyzers market heading? If you are involved in this sector you must read this newly...Full DetailsPublished: 01 January 1970Pyrogen Testing Market Report 2021-2031
Where the Pyrogen Testing is market heading? If you are involved in this sector you must read this newly updated...Full DetailsPublished: 01 January 1970
Download sample pages
Complete the form below to download your free sample pages for Automated Cannabis Testing Market Report to 2031Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Sara Peerun stating your chosen report title to sara.peerun@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2023-2033
The global Clinical Trial Supply and Logistics for Pharma market is valued at US$13.8 billion in 2023 and is projected to grow at a CAGR of 8.4% during the forecast period 2023-2033.
25 September 2023
Visiongain Publishes Anti-infective Vaccines Market Report 2023-2033
The global Anti-infective Vaccines market is valued at US$48,360.4 million in 2023 and is projected to grow at a CAGR of 6.6% during the forecast period 2023-2033.
21 September 2023
Visiongain Publishes Contract Research Organisations (CROs) Market Report 2023-2033
The global Contract Research Organisations (CROs) market was valued at US$68.9 billion in 2023 and is projected to grow at a CAGR of 10.6% during the forecast period 2023-2033.
14 September 2023
Visiongain Publishes Stem Cell Therapy Contract Manufacturing Market Report 2023-2033
The global Stem Cell Therapy Contract Manufacturing market was valued at US$2,495.1 million in 2022 and is projected to grow at a CAGR of 12.4% during the forecast period 2023-2033.
13 September 2023
